NCT01043666View on ClinicalTrials.gov

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

PHASE3CompletedINTERVENTIONAL
Enrollment

1,126

Participants

Timeline

Start Date

December 21, 2009

Primary Completion Date

September 16, 2011

Study Completion Date

September 16, 2011

Conditions
Urinary Bladder, Overactive
Interventions
DRUG

YM178

oral

DRUG

Placebo

oral

DRUG

tolterodine ER

oral

Trial Locations (35)

Unknown

Beijing

Dalian

Fuzhou

Guangzhou

Hangzhou

Hubei

Hunan

Jiangsu

Liaoning

Nanjing

Shanghai

Ahmedabad

Gūrgaon

Jaipur

Lucknow

New Delhi

Pune

Busan

Chungcheong Namdo

Daegu

Daejeon

Gwangju

Gyeonggi-do

Incheon

Jeollabuk

Jeollanam

Kyonggi

Seoul

Chiayi City

Hualien City

Kaohsiung City

Taichung

Tainan City

Taipei

Taoyuan District

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY